A detailed history of Schonfeld Strategic Advisors LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 15,699 shares of CYTK stock, worth $862,503. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,699
Previous 39,614 60.37%
Holding current value
$862,503
Previous $2.78 Million 69.39%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $1.14 Million - $1.79 Million
-23,915 Reduced 60.37%
15,699 $850,000
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $2.27 Million - $3.85 Million
35,650 Added 899.34%
39,614 $2.78 Million
Q4 2023

Feb 14, 2024

SELL
$26.88 - $83.49 $266,568 - $827,970
-9,917 Reduced 71.44%
3,964 $330,000
Q3 2023

Nov 14, 2023

SELL
$29.46 - $36.61 $498,934 - $620,026
-16,936 Reduced 54.96%
13,881 $408,000
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $110,353 - $137,857
3,383 Added 12.33%
30,817 $1.01 Million
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $981,684 - $1.35 Million
-29,427 Reduced 51.75%
27,434 $965,000
Q4 2022

Feb 14, 2023

BUY
$35.77 - $51.11 $2.03 Million - $2.91 Million
56,861 New
56,861 $2.61 Million
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $2.41 Million - $3.48 Million
71,166 Added 867.88%
79,366 $3.12 Million
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $2.78 Million - $4.3 Million
-93,500 Reduced 91.94%
8,200 $302,000
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $762,020 - $1.03 Million
22,184 Added 27.9%
101,700 $4.64 Million
Q3 2021

Nov 16, 2021

BUY
$18.54 - $35.74 $1.1 Million - $2.12 Million
59,216 Added 291.7%
79,516 $2.84 Million
Q2 2021

Aug 16, 2021

BUY
$19.79 - $26.99 $401,737 - $547,897
20,300 New
20,300 $402,000
Q2 2020

Aug 14, 2020

SELL
$11.15 - $24.64 $147,882 - $326,800
-13,263 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.75 - $16.3 $116,051 - $216,186
13,263 New
13,263 $156,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.17B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.